Caris Life Sciences to Attend Q4 2025 Investor Conferences
Caris Life Sciences to Attend Q4 2025 Investor Conferences Caris Life Sciences to Attend Q4 2025 Investor Conferences PR Newswire IRVING, Texas, Nov. 17, 2025 IRVING, Texas, Nov. 17, 2025...
PR Newswire·3d ago
More News
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response PR...
PR Newswire·22d ago
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025 Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025 PR Newswire IRVING...
PR Newswire·28d ago
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025 Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025 PR Newswire IRVING, Texas, Oct. 14, 2025 IRVING, Texas, Oct...
PR Newswire·1mo ago
TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape
Tempus AI's PurIST test secures clinical validation, helping personalize treatment choices for advanced pancreatic cancer patients.
Zacks·2mo ago
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI...